Meal timing may ease diet stress for weight cyclers

NCT ID NCT07582952

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether changing how often women eat (meal frequency) can improve their confidence and reduce stress while dieting. It involved 72 women aged 25-55 who had a history of losing and regaining weight (weight cycling) and were overweight or obese. The goal was to see if a specific meal schedule helps them stick to a diet more easily and feel less stressed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

72 people

The number who actually took part.

Started

Aug 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 55 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female participants aged 25-55 years * Body mass index (BMI) between 25 and 35 kg/m² * having a history of weight fluctuations * Willingness to participate and provide informed consent Exclusion Criteria: * Presence of cardiovascular disease * Chronic kidney disease * Hypertension * Diagnosis of Type 1 or Type 2 diabetes mellitus * Pregnancy or breastfeeding * Use of any medication or dietary supplement for weight loss or fat reduction * Engagement in intense physical activity * No having a history of weight fluctuations * Menopausal status * Failure to attend scheduled follow-up visits * Non-adherence to the intervention protocol for three consecutive days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dietary self-efficiacy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight Weight Cycling

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara Medipol University

    Ankara, Altındağ, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.